Lang AE - Search Results

1

Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria.

Wilkens I, Heine J, Ruf VC, Compta Y, Porcel LM, Troakes C, Vamanu A, Downes S, Irwin D, Cohen J, Lee EB, Nilsson C, Englund E, Nemati M, Katzdobler S, Levin J, Pantelyat A, Seemiller J, Berger S, van Swieten J, Dopper E, Rozenmuller A, Kovacs GG, Bendahan N, Lang AE, Herms J, Höglinger G, Hopfner F. Wilkens I, et al. Among authors: lang ae. Mov Disord. 2024 Sep;39(9):1514-1522. doi: 10.1002/mds.29879. Epub 2024 Jun 7. Mov Disord. 2024. PMID: 38847384

2

Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials.

Quattrone A, Franzmeier N, Huppertz HJ, Klietz M, Roemer SN, Boxer AL, Levin J, Höglinger GU; AL‐108‐231 Investigators, the Tauros MRI Investigators, the PASSPORT Study Group, the DESCRIBE‐PSP Group. Quattrone A, et al. Mov Disord. 2024 Aug;39(8):1329-1342. doi: 10.1002/mds.29866. Epub 2024 Jun 2. Mov Disord. 2024. PMID: 38825840

3

Thalamic Local Field Potentials and Closed-Loop Deep Brain Stimulation in Orthostatic Tremor.

Fung WKW, Sumarac S, Sorrento G, Santyr B, Milosevic L, Lang AE, Lozano AM, Kalia SK, Fasano A. Fung WKW, et al. Among authors: lang ae. Mov Disord. 2024 Oct 25. doi: 10.1002/mds.30035. Online ahead of print. Mov Disord. 2024. PMID: 39450564

4

Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.

Zimmerman TR Jr, Sage JI, Lang AE, Mark MH. Zimmerman TR Jr, et al. Among authors: lang ae. Mov Disord. 1994 Mar;9(2):173-7. doi: 10.1002/mds.870090208. Mov Disord. 1994. PMID: 8196678

5

Reversible dopamine agonist induced anterocollis in a multiple system atrophy patient.

Prakash KM, Lang AE. Prakash KM, et al. Among authors: lang ae. Mov Disord. 2007 Nov 15;22(15):2292-3. doi: 10.1002/mds.21729. Mov Disord. 2007. PMID: 17914721 No abstract available.

6

Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine.

Walsh RA, Lang AE. Walsh RA, et al. Among authors: lang ae. Mov Disord. 2012 Feb;27(2):326. doi: 10.1002/mds.23964. Epub 2011 Sep 27. Mov Disord. 2012. PMID: 21954056 No abstract available.

7

Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD).

Parkinson Study Group. Parkinson Study Group. Mov Disord. 2013 Nov;28(13):1823-31. doi: 10.1002/mds.25639. Epub 2013 Sep 30. Mov Disord. 2013. PMID: 24123224 Clinical Trial.

8

Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to low-dose quetiapine.

Walsh RA, Lang AE. Walsh RA, et al. Among authors: lang ae. Mov Disord. 2011 Oct;26(12):2297-8. doi: 10.1002/mds.23831. Epub 2011 Jul 6. Mov Disord. 2011. PMID: 21735479 No abstract available.

9

Crossing the borders between neurology and psychiatry in functional neurological disorders.

Peralta V, Lang AE. Peralta V, et al. Among authors: lang ae. Mov Disord. 2011 Jul;26(8):1373-4. doi: 10.1002/mds.23804. Mov Disord. 2011. PMID: 22052560 No abstract available.

10

Alien hand syndrome and dystonia in a pediatric patient.

Soman T, Steeves TD, Lang AE. Soman T, et al. Among authors: lang ae. Mov Disord. 2009 Jul 30;24(10):1557-9. doi: 10.1002/mds.22620. Mov Disord. 2009. PMID: 19424987 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,167 results

Search Page

Filters